Novarex Co (194700.KQ) Stock Price

Novarex Co Price

CLOSED
9,920.00
​
Market closed

Revenue has compounded at 17.2% per year over the past 10 years to 404.26 B KRW. Earnings per share have grown at 12.4% per year over the last 10 years. Novarex Co's net margin stands at 8.8%, broadly stable from 9.5% several years earlier. Novarex Co currently offers a dividend yield of about 4.03%. The payout ratio is around 20% of earnings. The dividend has grown at 22.3% per year over the past 7 years. Analysts set a median price target of 23,460.00 KRW, implying 136.5% above the current price. Of 5 analysts, 4 rate the stock a buy — an overall Buy consensus.

Novarex Co stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Novarex Co business model & stock analysis

Novarex Co Ltd, based in Cheongju, South Korea, operates in the Consumer Staples sector, specializing in manufacturing and selling dietary supplements. The company produces health functional foods, including vitamin and mineral supplements, body fat reduction products, eye and joint health solutions, lactic acid bacteria products for skin care, coenzyme Q10, wild mango seed extract, and spirulina. Novarex distributes its products domestically and internationally, with an IPO listed on 14 November 2018.

Frequently asked questions about Novarex Co

Analysts currently set an average price target of 23,460.00 KRW for the Novarex Co stock (median: 23,460.00 KRW), implying +136.5 % versus the latest price. The consensus is based on 5 analyst ratings.

5 analysts currently rate the Novarex Co stock: 4 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Novarex Co to generate revenue of 490.30 B KRW and earnings per share of 2,474.00 KRW.

Converted at the current exchange rate, the Novarex Co share trades at 6.61 EUR (9,920.00 KRW).

The expected revenue of Novarex Co is 490.30 B KRW. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Novarex Co is 43.80 B KRW. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Novarex Co is currently 4.01. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Novarex Co stock.

The price-to-sales ratio (P/S) of Novarex Co is currently 0.36. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Novarex Co stock.

The Eulerpool Quality Score for Novarex Co is 7/10.

The ISIN of Novarex Co is KR7194700001. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Novarex Co is 194700.KQ. The ticker symbol is used to trade Novarex Co shares on the stock exchange.

Fair ValueTerminal
8,531.20 KRW
Over-/UndervaluationTerminal
Fairly valued
Industry
Personal Care Products
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
South Korea
Currency
KRW
Initial public offering
Nov 14, 2018
ISIN
KR7194700001
Cusip
Y6S74Z103
Market capitalization
175.61 B KRWLarge Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
4.01
P/Ee 2027
3.44
P/S
P/Se
0.36
EV/EBIT
2.94
P/B Ratio
0.69
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
13.65 %
Dividend
Dividend yield
4.03 %
Est. Dividend Yield
7.26 %
Payout Ratio
19.99 %
Dividend growth Ø5Y
22.17 %
Dividend payments per year
1
Dividend paid since
8 years
Dividend not reduced since
8 years
Dividend increased since
1 year
Dividend withholding tax
22.00 %
Last updated Oct 17, 2026, 6:57 PM

Novarex Co Peer Group

Novarex Co FIGI

194700:KS · BBG00M6GTKZ5194700:KQ · BBG00M6GTL10

All fundamentals and in-depth analysis of Novarex Co

Our stock analysis for Novarex Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Novarex Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.